Neurology Updates

Neurology Updates

Here you will find regular scientific news from our Scientific Panels. We cover all areas of neurology, including rare diseases. The most recent news are displayed below. You will find all news of different areas sorted into the subsections of the respective scientific panel. Enjoy reading!

Process for SP Submissions

If you want to submit a neurology update for your scientific panel, please find related information here:

| ALS and frontotemporal dementia | Rare Neurological Diseases  

Amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) show similarities in pathology and genetics, hinting at shared…

more...
| ALS and frontotemporal dementia | Rare Neurological Diseases  

This article provides a comprehensive review of the studies using non-invasive brain and spinal stimulation in motor neuron disease, with a focus on…

more...
| ALS and frontotemporal dementia | Rare Neurological Diseases  

This study provides further insights in the consequences of mislocalization of the protein TDP-43 from the nucleus to the cytoplasm which is a…

more...
| Palliative Care | Rare Neurological Diseases  

Virtual palliative care consultation for people with ALS, and their caregivers, was found to be helpful and did not take too much energy or cause…

more...
| Rare Neurological Diseases  

A modified RT-QuIC assay combined with immunoprecipitation for the detection of α-synuclein fibrils appears to be a good blood biomarker for…

more...
| Rare Neurological Diseases  

The FDA has approved Omaveloxolone for the treatment of Friedrich ataxia (FA). Omaveloxone improved neurological function assessed with the modified…

more...
| Neuroscience/ Translational neurology | Rare Neurological Diseases  

Mader et al. dissect the MOG IgG effector mechanisms that characterize MOG-antibody-associated disease. FcR pathway mediates the MOG-Abs enhanced…

more...
| Rare Neurological Diseases | Sleep disorders  

The study validated a screening questionnaire for pediatric narcolepsy, which showed high sensitivity and specificity in identifying affected…

more...
| Higher Cortical Functions | Rare Neurological Diseases  

A “Mini Linguistic State Examination”, was developed to assess and classify language disorders in patients with primary progressive aphasia (PPA).…

more...
| Muscle & Neuromuscular Junction Disorders | Rare Neurological Diseases  

Rozanolixizumab is subcutaneous infused monoclonal antibody targeting the neonatal Fc receptor (FcRn) in adult with MG.

As already presented…

more...
| Muscle & Neuromuscular Junction Disorders | Rare Neurological Diseases  

An interim analysis of the phase 3 open-label extension study (RAISE-XT) testing zilucoplan (a self-administered subcutaneous complement C5 inhibitor)…

more...
| Muscle & Neuromuscular Junction Disorders | Rare Neurological Diseases  

Eculizumab (Soliris; Alexion) is an intravenous complement C5 inhibitor originally approved by FDA and EMA in adult’s patient with anti-acetylcholine…

more...